Latest news
Hopstem’s iPSC-Derived hNPC01 Cell Therapy Gains FDA Clearance to Target Three Major Brain Injury Indications - BioInformantBioInformant · Wed, 05 Aug 2026 21:57:41 GMTIPSC Q2'26 Earnings: EPS estimate is (0.11) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:37 GMTSeven Fleet Capital Management LP Takes Position in Century Therapeutics, Inc. $IPSC - MarketBeatMarketBeat · Sun, 02 Aug 2026 10:50:53 GMTEUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products - finance.yahoo.comfinance.yahoo.com · Thu, 30 Jul 2026 07:00:00 GMTEUDA Health Holdings Signs MOU with GO POSB and SIIT for iPSC-Based Oncology Cell Therapy Collaboration - Quiver QuantitativeQuiver Quantitative · Tue, 28 Jul 2026 10:13:00 GMT